Search results for " CELL CARCINOMA"

showing 10 items of 477 documents

A phase I-II study on intravesical Gemcitabine in superficial bladder papillary tumors

2004

INTRODUCTION AND OBJECTIVE: The possible role of gemcitabine inintravesical therapy of superficial transitional cell carcinoma of the bladder (TCCB) has been suggested. The European Organization for Research and Treatment of Cancer Urological Group validated the use of papillary marker lesion left in the bladder after TUR as the best tool to measure the efficacy of a drug by intravesical route against TCCB. The rsults on 27 patients are herein presented. METHODS: Twenty-seven patients, with recurrent superficial TCCB (Ta-T1, G1-G2), were treated with intravesical gemcitabine for 1 to 3 papillary marker lesions (5-15 mm) left unreseacted after TUR. Twenty-one patients (78%) had recurrent tum…

intravesical therapy of superficial transitional cell carcinoma of the bladder (TCCB)gemcitabineSettore MED/24 - Urologia
researchProduct

Prediction of significant renal function decline after open, laparoscopic, and robotic partial nephrectomy: External validation of the Martini’s nomo…

2022

Objectives: Martini et al. developed a nomogram to predict significant (>25%) renal function loss after robot-assisted partial nephrectomy and identified four risk categories. We aimed to externally validate Martini’s nomogram on a large, national, multi-institutional data set including open, laparoscopic, and robot-assisted partial nephrectomy. Methods: Data of 2584 patients treated with partial nephrectomy for renal masses at 26 urological Italian centers (RECORD2 project) were collected. Renal function was assessed at baseline, on third postoperative day, and then at 6, 12, 24, and 48 months postoperatively. Multivariable models accounting for variables included in the Martini’s nomog…

laparoscopy; nephron-sparing surgery; renal cell carcinoma; renal function; robotics; Humans; Kidney; Nephrectomy; Nomograms; Kidney Neoplasms; Laparoscopy; Robotic Surgical Procedures; Roboticsroboticsrenal cell carcinomaUrologyrenal functionlaparoscopynephron-sparing surgeryKidneyNephrectomyKidney NeoplasmsNomogramsRobotic Surgical ProceduresHumansLaparoscopyrobotics.Laparoscopy; nephron-sparing surgery; renal cell carcinoma; renal function; robotics.International Journal of Urology
researchProduct

Is the Complement Protein C1q a Pro- or Anti-tumorigenic Factor? Bioinformatics Analysis Involving Human Carcinomas

2019

C1q is the first subcomponent of the classical pathway of the complement system and belongs to the C1q/Tumor Necrosis Factor superfamily. C1q can perform a diverse range of immune and non-immune functions in a complement-dependent as well as -independent manner. Being a pattern recognition molecule of the innate immunity, C1q can recognize a number of self, non-self and altered-self ligands and bring about effector mechanisms designed to clear pathogens via opsonisation and inflammatory response. C1q is locally synthesized by macrophages and dendritic cells, and thus, can get involved in a range of biological processes, such as angiogenesis and tissue remodeling, immune modulation, and immu…

lcsh:Immunologic diseases. Allergy0301 basic medicinetumorLung NeoplasmsMicroenvironmentPrognosiImmunologyComplementBreast Neoplasmschemical and pharmacologic phenomenaKaplan-Meier EstimateBiology03 medical and health sciencesClassical complement pathway0302 clinical medicineImmune systemimmune system diseasesmedicineHumansImmunology and Allergycomplementclassical pathwayskin and connective tissue diseasesC1qOriginal ResearchTumorInnate immune systemEffectorComplement C1qComputational BiologyCancerPrognosismedicine.diseasemicroenvironmentKidney NeoplasmsComplement systemClear cell renal cell carcinomaC1q; Classical pathway; Complement; Microenvironment; Prognosis; Tumor030104 developmental biologyClassical pathwayCancer researchAdenocarcinomaprognosislcsh:RC581-607030215 immunologyFrontiers in Immunology
researchProduct

CT and MR imaging of cystic renal lesions

2020

AbstractCystic renal lesions are a common incidental finding on routinely imaging examinations. Although a benign simple cyst is usually easy to recognize, the same is not true for complex and multifocal cystic renal lesions, whose differential diagnosis includes both neoplastic and non-neoplastic conditions. In this review, we will show a series of cases in order to provide tips to identify benign cysts and differentiate them from malignant ones.

lcsh:Medical physics. Medical radiology. Nuclear medicinemedicine.medical_specialtymedicine.diagnostic_testbusiness.industrySimple cystlcsh:R895-920UltrasoundInterventional radiologyMRMr imagingBenign cystsCystic renal lesionCystic renal cell carcinomamedicineRadiology Nuclear Medicine and imagingRadiologyDifferential diagnosisbusinessBosniakNeuroradiologyEducational ReviewCTInsights into Imaging
researchProduct

Prevalence and morphometric analysis of the retromolar canal in a Spanish population sample: a helical CT scan study.

2021

BACKGROUND: The retromolar canal (RMC) is an anatomical variation of the mandibular canal (MC) whose identification and study should be considered given its implication in the surgical procedures of the retromolar area. The prevalence of the RMC widely varies according to previous studies and may be influenced by the followed study method. This work aimed to evaluate the prevalence of the RMC in a Spanish population sample. MATERIAL AND METHODS: For this purpose, 225 CT scan images (with a higher resolution than the cone beam CT used in other previous studies) from the Hospital Clinico Universitario de Valencia were analyzed. The Osirix MD radiological image analysis system was applied to a…

locoregional recurrencehpv-16Mandibular canalMandiblesurvivaldisease progressionmedicinePrevalenceHumanshuman papillomavirusGeneral DentistryCone beam ctUNESCO:CIENCIAS MÉDICASOrthodonticshpvbusiness.industryAnatomic VariationSurgical proceduresCone-Beam Computed Tomographyoral cancerHelical ctClinical PracticeSpanish populationoral squamous cell carcinomamedicine.anatomical_structureOtorhinolaryngologyMorphometric analysisRadiological weaponSurgerybusinessTomography Spiral Computed
researchProduct

Alterations of panoramic radiomorphometric indices in children and adolescents with beta-thalassemia major: A fractal analysis study

2021

Background Beta-thalassemia major is an inherited disorder that can cause bone deformity and loss of bone mineral density. The objective of this study is to evaluate the cortical and trabecular mandibular bone morphology of children and adolescents who have beta-thalassemia major (ß-TM) using a fractal dimension (FD) analysis and different panoramic radiomorphometric indices with digital panoramic radiographic images (DPRIs). Material and Methods The study included 80 patients (with 40 patients each of ß-TM and control). The mandibular cortical width (MCW), panoramic mandibular index (PMI), mandibular cortical index (MCI), and simple visual estimation (SVE) were evaluated, and an FD analysi…

malignant transformationAdolescentResearchbeta-ThalassemiamirnasbiomarkersMandibleMedically compromised patients in Dentistryoral leukoplakiaoral squamous cell carcinomaFractalsOtorhinolaryngologyBone Densitymental disordersRadiography PanoramicHumansSurgeryChildGeneral DentistryUNESCO:CIENCIAS MÉDICASMedicina Oral, Patología Oral y Cirugía Bucal
researchProduct

Metástasis óseas secundarias a carcinoma renal diagnosticadas mediante gammagrafía ósea

2001

We reported the case of a 35-y-old man with renal cell carcinoma and cold lesions detected by bone scintigraphy, related to metastatic involvement. Conventional X-Ray did not show any pathological findings, being confirmed by axial computed tomography (CT) the scintigraphic bone lesions. We have accomplished a discussion of the role of bone scintigraphy and complementary techniques (radiography, alkaline phosphatase levels) in the diagnosis of bone metastases in renal cell carcinoma.

medicine.diagnostic_testbusiness.industryUrologyRadiographyComputed tomographymedicine.diseaseBone scintigraphyRenal cell carcinomaBone lesionCarcinomaMedicineAlkaline phosphatasebusinessNuclear medicinePathologicalActas Urológicas Españolas
researchProduct

Identification of markers for the selection of patients undergoing renal cell carcinoma-specific immunotherapy

2003

Renal cell carcinoma (RCC) represents the most common malignant tumor in the kidney and is resistant to conventional therapies. The diagnosis of RCC is often delayed leading to progression and metastatic spread of the disease. Thus, validated markers for the early detection of the disease as well as selection of patients undergoing specific therapy is urgently needed. Using treatment with the monoclonal antibody (mAb) G250 as a model, proteome-based strategies were implemented for the identification of markers which may allow the discrimination between responders and nonresponders prior to application of G250-mediated immunotherapy. Flow cytometry revealed G250 surface expression in approxi…

medicine.drug_classmedicine.medical_treatmentMonoclonal antibodyBiochemistryMass SpectrometryFlow cytometrySequence Analysis ProteinRenal cell carcinomaCell Line TumorBiomarkers TumormedicineCarcinomaHumansElectrophoresis Gel Two-DimensionalCarcinoma Renal CellMolecular Biologybiologymedicine.diagnostic_testAntibodies MonoclonalProteinsImmunotherapyFlow Cytometrymedicine.diseaseKidney NeoplasmsImmunologyProteomebiology.proteinCancer researchImmunohistochemistryImmunotherapyAntibodyPROTEOMICS
researchProduct

Sunitinib related osteonecrosis of the jaw (SURONJ): a rare occurrence?

2015

Sir, Sunitinib is a drug approved in 2006 by the FDA for the treatment of renal cell carcinoma (RCC) and resistant gastrointestinal stromal tumor (GIST). The capillary endothelium is the first target of sunitinib: it blocks several pathways central to proliferation, migration, differentiation, neoangiogenesis, and invasion of cancer cells, including vascular endothelial growth factor receptors (VEGFRs), plateletderived growth factor receptors (PDGFR-α and PGRF-β), the stem cell factor receptor (c-Kit) and the Fms-like tyrosine kinase 3 (FLT3), and glial cell–derived neurotrophic factor receptor (RET), colony-stimulating factor type 1 (CSF-1R) [1, 2, 9]. In literature, several adverse effect…

medicine.medical_specialtyChemotherapybusiness.industrySunitinibmedicine.medical_treatmentOsteomyelitis030206 dentistrymedicine.diseaseNephrectomySurgerySunitinib osteonecrosis03 medical and health sciences0302 clinical medicineDental extractionRenal cell carcinoma030220 oncology & carcinogenesismedicineMucositisSurgerybusinessOsteonecrosis of the jawmedicine.drug
researchProduct

Head–Neck Cancer Delineation

2021

Head–Neck Cancer (HNC) has a relevant impact on the oncology patient population and for this reason, the present review is dedicated to this type of neoplastic disease. In particular, a collection of methods aimed at tumor delineation is presented, because this is a fundamental task to perform efficient radiotherapy. Such a segmentation task is often performed on uni-modal data (usually Positron Emission Tomography (PET)) even though multi-modal images are preferred (PET-Computerized Tomography (CT)/PET-Magnetic Resonance (MR)). Datasets can be private or freely provided by online repositories on the web. The adopted techniques can belong to the well-known image processing/computer-vision a…

medicine.medical_specialtyComputer sciencemedicine.medical_treatmentImage processinghead–neck cancer (HNC)Head neck cancerlcsh:Technology030218 nuclear medicine & medical imagingTask (project management)head and neck squamous cell carcinoma (HNSCC)lcsh:Chemistry03 medical and health sciencestumor delineation0302 clinical medicinemedicineGeneral Materials ScienceMedical physicsSegmentationlcsh:QH301-705.5InstrumentationSettore ING-INF/05 - Sistemi Di Elaborazione Delle InformazioniFluid Flow and Transfer Processesmedicine.diagnostic_testlcsh:Tbusiness.industryProcess Chemistry and TechnologyDeep learningsegmentationGeneral EngineeringCT Head and neck squamous cell carcinoma (HNSCC) Head–neck cancer (HNC) MRI Nasopharyngeal cancer (NPC) PET Segmentation Tumor delineationnasopharyngeal cancer (NPC)lcsh:QC1-999Computer Science ApplicationsRadiation therapylcsh:Biology (General)lcsh:QD1-999lcsh:TA1-2040Positron emission tomography030220 oncology & carcinogenesisArtificial intelligenceTomographylcsh:Engineering (General). Civil engineering (General)businesslcsh:PhysicsCTApplied Sciences
researchProduct